Flerie AB | FLERIE Logo | Annual Report & Investor Relations Data

Flerie AB | FLERIE Annual Report & Investor Relations Data

ISIN

SE0022447348

Ticker

FLERIE

Sector

Health Care

Industry

Pharmaceuticals

Country

Sweden

Year Founded

2011

Flerie AB (FLERIE)
Company Overview & Profile

Company Description

Flerie AB is a pharmaceutical company focusing on immunological diseases with great medical needs for new treatment options. The portfolio of the company includes Immuno-Oncology, metabolic diseases, and biologics development and manufacturing organizations.

Flerie was established in 2011 by Thomas Eldered, who co-founded and built one of the global top five drug manufacturers, Recipharm. Dr Carl-Johan Spak, now Senior Advisor, and Thomas laid the foundation for Flerie’s evergreen strategy and oversaw the early investments. Flerie sold Cormorant Pharmaceuticals to BMS in 2016 and Cobra Biologics to Cognate Bioservices in early 2020 – this enabled further investments. In 2018, Dr Ted Fjällman, then chief executive of one of the portfolio companies, joined as Venture Partner, later Partner and CEO of Flerie.

Served Area

Worldwide

Headquarters

Skeppsbron 16
111 30, Stockholm
Sweden

Flerie AB (FLERIE)
Filings & Annual Reports

Filters

View all types
Type Document Details Language Filing Date File Number

Get Early API Access

Access comprehensive European stock market filings data through a single, powerful API.

1,5M+

filings covered

18

European countries

30min

max latency

1 API

for all filings

Request Early Access

Limited spots available. Join now!

Flerie AB (FLERIE)
Leadership: Management & Supervisory Board

No Leadership Information Available

We currently don't have information about the management or supervisory board for this company. This information will be updated as soon as it becomes available.

Flerie AB (FLERIE)
Stock & Investor Information

ISIN

SE0022447348

LEI

54930047C4A74IBXR037

Stock Exchange Listings

Nasdaq Stockholm

Industry Classification

Flerie AB (FLERIE)
Related Companies & Peer Group

ABIVAX Logo

ABIVAX

ABVX

Sector

Health Care

Country

France

ISIN

FR0012333284

Founded

Abivax develops innovative treatments modulating the body’s natural immune system machinery to treat patients with chronic inflammatory diseases, viral infections …

Addex Therapeutics Ltd Logo

Addex Therapeutics Ltd

ADXN

Sector

Health Care

Country

Switzerland

ISIN

CH0029850754

Founded

2002

Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally …

AegirBio AB Logo

AegirBio AB

AEGIR

Sector

Health Care

Country

Sweden

ISIN

SE0014401121

Founded

2019

AegirBio is a Swedish diagnostics company that was founded to offer tests to monitor and optimize the dosage of biological …

Alkaloid AD Logo

Alkaloid AD

None

Sector

Health Care

Country

North Macedonia

ISIN

MKALKA101011

Founded

1936

Alkaloid AD Skopje is a company which more than eight and a half decades, has been operating in the field …

Antibiotice S.A. Logo

Antibiotice S.A.

ATB

Sector

Health Care

Country

Romania

ISIN

ROATBIACNOR9

Founded

1955

The leading manufacturer of generic drugs in Romania, Antibiotice SA was founded in December 1955. The company was listed on …

AstraZeneca PLC Logo

AstraZeneca PLC

AZN

Sector

Health Care

Country

United Kingdom

ISIN

GB0009895292

Founded

1999

We are a global, science-led, patient-focused pharmaceutical company. We are tireless in seeking to realise the potential of what science …